Home / Compositions and Methods for Treating Vascular Disorders
Tulane is actively seeking commercial entities to further develop and commercialize our novel composition of viral vectors for impairment of pathological angiogenesis
Anti-angiogenic therapy for treatment of age-related macular degeneration, atherosclerosis, diabetic retinopathy, and cancer
Proof-of-concept studies completed.